Petrello A, Yared J, Onukwugha E, Slejko JF.
Slejko JF, Rueda JD, Trovato JA, Gorman EF, Betz G, Arcona S, Zacker C, Stuart B
Measuring Oral Oncolytic Dose Intensity using Pharmacy Claims Data
AMCP Nexus. October 22-25, 2018, Orlando, FL.
Gordon C, Gray C, Mahler JA, Rueda JD, Slejko JF
ISPOR 23rd Annual International Meeting. May 20-24, 2018. Baltimore, MD.
Mahler JA, Gordon C, Gray C, Rueda JD, Slejko JF
AMCP Managed Care & Specialty Pharmacy Annual Meeting. April 23-26, 2018. Boston, MA.
Onwudiwe NC, Slejko JF, Mattingly J, Levy JF.
TRANSFERABILITY OF ECONOMIC EVALUATION STUDIES: IS THERE A GENERALLY ACCEPTED ALTERNATIVE PRICE BENCHMARK TO THE WAC PRICE? (Invited Workshop)
ISPOR 22nd Annual International Meeting. May 20-24, 2017. Boston, MA.
Slejko JF, Rueda JD, Cooke CE, Shen X, Ciarametaro M, Dubois RW, Stuart B
ASSESSING THE EFFECT OF FORMULARY RESTRICTIONS ON ANTIHYPERGLYCEMIC DRUGS
ISPOR 21st Annual International Meeting. May 21-25, 2016. Washington, DC.
Rueda JD, Slejko JF, Cooke C, Shen X, Ciarametaro M, Dubois R, Stuart B.
Building the Evidence Base for Evaluating Complex Formulary Designs in Type 2 Diabetes Mellitus
2016 Annual Research Meeting, June 26-28, 2016. Boston, MA.